BioStacks

Supplement

Yeast Peptide DNF-10

Evidence

Limited
Evidence: 2 of 5 (Limited)

What the evidence says

DNF-10 is a branded, low-molecular-weight (<10 kDa) peptide hydrolysate of Saccharomyces cerevisiae (baker's yeast), manufactured by Neo Cremar and GRAS-affirmed by FDA (GRN 1033) for use in foods/beverages.

GRAS safety status confirmed by FDA; clinical-efficacy evidence is preliminary/manufacturer-associated, not independently validated by RCTs.

Top Yeast Peptide DNF-10 supplements

About Yeast Peptide DNF-10

DNF-10 is a branded, low-molecular-weight (<10 kDa) peptide hydrolysate of Saccharomyces cerevisiae (baker's yeast), manufactured by Neo Cremar and GRAS-affirmed by FDA (GRN 1033) for use in foods/beverages. It's marketed for appetite/satiety support via proposed ghrelin and neuropeptide Y modulation. Evidence is limited to manufacturer-associated animal and preliminary studies; no independent peer-reviewed human RCTs confirming clinical weight-management outcomes were identified.

What Yeast Peptide DNF-10 supports

  • Marketed for appetite/satiety support via ghrelin modulation — evidence is mostly manufacturer-associated and preclinical, independent human RCTs are lacking

Clinical evidence

Limited clinical evidence. GRAS safety status confirmed by FDA; clinical-efficacy evidence is preliminary/manufacturer-associated, not independently validated by RCTs.

Reference